Analysts Say Glenmark, Cipla’s Covid-19 Medicines To Benefit In Short Term, But…
A medic collects a swab sample of a man from a new swab testing cabin at Podar hospital in Worli during a nationwide lockdown in the wake of coronavirus pandemic, in Mumbai. (Source: PTI)

Analysts Say Glenmark, Cipla’s Covid-19 Medicines To Benefit In Short Term, But…

Analysts expect the launch of two anti-viral drugs to treat Covid-19 patients to benefit Glenmark Pharmaceuticals Ltd. and Cipla Ltd. in short term but subside as competition increases.Glenmark rec...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.